Zdrowie i gospodarka · 06/05/2026
FDA Classifies Device for Preserving Microbial Nucleic Acids into Class II
The FDA has classified a device for preserving and stabilizing microbial nucleic acids in clinical samples into Class II, a move aimed at ensuring safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.
Source: Federal Register — Food and Drug AdministrationOpen original release →